Lilly shares rise on possibility for Alzheimer’s drug
Eli Lilly and Co. stock rose to a one-month high Tuesday after an analyst said the possible success of the company’s experimental Alzheimer’s drug could double the share price.
Eli Lilly and Co. stock rose to a one-month high Tuesday after an analyst said the possible success of the company’s experimental Alzheimer’s drug could double the share price.
OneAmerica earned $15.4 million in the three months ended Sept. 30, down 53 percent from the same quarter a year ago. Most of that difference came from a 17-percent jump in policy benefit payments.
Carmel resident David Wasilewski has launched WhatNext, a website that uses algorithms to make it easier for cancer patients to connect with others in similar circumstances. Wasilewski, 39, spent eight years as chief operating officer of the Spanx line of body shapers and did health care consulting before that. In addition to helping patients, he thinks WhatNext can become a way for health care organizations share their expertise with patients in need.
In spite of all the consolidation lately among hospitals, Community Health CEO Bryan Mills says the future of hospital systems will hinge more on partnerships like the one Community struck last week on its rehab hospital.
The Obama administration on Friday let stand an earlier rule that said brokers’ fees will have to count toward a 15-percent to 20-percent cap on administrative expenses placed on insurance plans by the 2010 health overhaul.
Takeda Pharmaceutical Co. and marketing co-partner Eli Lilly and Co. may face as many as 10,000 lawsuits in U.S. courts over allegations that their Actos diabetes drug causes bladder cancer.
Indianapolis-based WellPoint Inc., the largest U.S. health insurer by enrollment, will favor a copy of the blockbuster cholesterol medication made by Watson Pharmaceuticals Inc., the insurer said.
A New York dental chain that closed offices in 13 states, including eight in Indiana, without warning late last year lists no assets and liabilities of $3.6 million in a bankruptcy filing.
Federal officials announced Tuesday they are awarding more money to help states carry out President Barack Obama's health care overhaul. Seven states that are suing to overturn the landmark law are also on the list for funding.
Indiana’s largest and busiest medical system committed 19 preventable errors last year at its hospitals in Indianapolis and other cities, three fewer than in 2009, according to a report released Monday.
The state report cited 34 stage three or stage four bed sores after hospital admissions. It also found 33 foreign objects left behind after surgeries.
Indianapolis-based Eli Lilly and Co. recently rejected CVS Caremark’s demands for big price discounts on its insulins, leading CVS to kick Lilly’s insulins off its list of recommended drugs.
The National Association of Insurance Commissioners passed a resolution Nov. 22 that urges Congress and the Obama administration to exclude benefits brokers’ commissions from the new requirement that insurers spend only 15 percent to 20 percent of the premiums they collect on administration and profits.
Regulators allege CEO Patrick G. Rooney diverted millions of dollars from a hedge fund into the struggling Fishers company without investors’ knowledge.
Community Health Network plans to move its inpatient rehabilitation facility from its east-side hospital to a new $23 million, 60-bed facility in the Castleton neighborhood.
Indianapolis-based Anthem Blue Cross and Blue Shield and Minnesota-based UnitedHealthcare say they’re responding to demands from employers, who are desperate to rein in spiraling health benefits costs and have begun embracing the idea that to do so they must change their workers’ approach to health and health care.
Raising prices is easier when numbers are limited.
Smart coalitions will cut costs, improve quality.
Metrics make a difference in health care facilities.
For Indiana’s life sciences sector, the change both raises hopes and creates challenges for continued growth.